Mogrify adds Dr. Lorenz Mayr to Board of Directors and Scientific Advisory Board
Cambridge, UK, 7th July 2020: Mogrify Ltd (Mogrify®), a UK biotechnology company [...]
Dotmatics acquires BioBright to accelerate laboratory data automation for the Lab of the Future
Complementary expertise provides a single vendor solution to streamline data [...]
Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva
Positive initial data from first Affimer-based rapid test strips for [...]
TTP plc selected for technology advisory partnership with Cancer Research UK
Agreement to harness TTP’s industry expertise to assess the potential [...]
Start Codon showcases the first cohort of companies from its life science business acceleration programme
Start Codon aims to rapidly translate the most disruptive and [...]
Dexamethasone identified by AI VIVO as high potential for treatment of COVID-19 ten weeks ago
Dexamethasone was shown to save the lives of seriously ill [...]
Avacta provides update on Affimer therapy for COVID-19 infection
Infectivity assays carried out in collaboration with Glasgow University show [...]
BIA Separations introduces PrimaS multi-mode ligand bioprocessing technology to facilitate development of advanced therapeutics
Novel platform initially focussed on high-resolution industrial scale processing of [...]
Dante Labs, Cambridge Cancer Genomics and Nonacus collaborate to provide precision oncology at scale
Partnership aims to deliver the most comprehensive, cost effective and [...]
Avacta provides update on COVID-19 antigen diagnostic test development with Adeptrix
Highly specific prototype test detects the virus spike protein at [...]